Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

BACKGROUND: Calcium release-activated calcium (CRAC) channel inhibitors stabilize the pulmonary endothelium and block proinflammatory cytokine release, potentially mitigating respiratory complications observed in patients with COVID-19. This study aimed to investigate the safety and efficacy of Auxo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Joseph, Bruen, Charles, Schnaus, Michael, Zhang, Jeffrey, Ali, Sadia, Lind, April, Stoecker, Zachary, Stauderman, Kenneth, Hebbar, Sudarshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427272/
https://www.ncbi.nlm.nih.gov/pubmed/32795330
http://dx.doi.org/10.1186/s13054-020-03220-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427272/
https://www.ncbi.nlm.nih.gov/pubmed/32795330
http://dx.doi.org/10.1186/s13054-020-03220-x

Ejemplares similares